Clinicians should use a standard prophylactic anticoagulant dose over higher doses to prevent clotting in patients who have been hospitalised with COVID-19, including those in intensive care, according to new guidelines from the American Society of Hematology. The guidelines, which address both critically and acutely ill hospitalised patients, were put together by a multidisciplinary, internationally ...
Preventive anticoagulation in COVID-19 should be given at a standard dose: ASH
By Nicola Garrett
14 Oct 2020